# CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy

> **NCT04913896** · — · UNKNOWN · sponsor: **The First Hospital of Jilin University** · enrollment: 200 (estimated)

## Conditions studied

- Gastric Cancer
- Magnetic Resonance Imaging
- Tomography, X-Ray Computed
- Neoadjuvant Immunotherapy
- Neoadjuvant Chemotherapy

## Interventions

- **DRUG:** PD-1 inhibitor

## Key facts

- **NCT ID:** NCT04913896
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04913896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04913896, "CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04913896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*